Excitingly, endothelial-specific IGFBP-7 knockout and therapeutic targeting of IGFBP-7 using a vaccine-based approach both ameliorated cardiac dysfunction in a pressure overload model of heart failure [103]. The gene discussed is IGFBP7; the disease is heart failure.